Hinova Pharmaceuticals (SHSE:688302) Cash Flow for Dividends : ¥-0.03 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Hinova Pharmaceuticals Cash Flow for Dividends?

Hinova Pharmaceuticals's cash flow for dividends for the three months ended in Sep. 2024 was ¥-0.12 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.03 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Hinova Pharmaceuticals's quarterly payment of dividends declined from Mar. 2024 (¥-0.15 Mil) to Jun. 2024 (¥-0.12 Mil) and declined from Jun. 2024 (¥-0.12 Mil) to Sep. 2024 (¥-0.12 Mil).

Hinova Pharmaceuticals's annual payment of dividends increased from Dec. 2021 (¥-2.56 Mil) to Dec. 2022 (¥-3.92 Mil) but then declined from Dec. 2022 (¥-3.92 Mil) to Dec. 2023 (¥-0.90 Mil).

Hinova Pharmaceuticals Cash Flow for Dividends Historical Data

The historical data trend for Hinova Pharmaceuticals's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hinova Pharmaceuticals Cash Flow for Dividends Chart

Hinova Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-0.39

-0.36

-2.56

-3.92

-0.90

Hinova Pharmaceuticals Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash Flow for Dividends	Get a 7-Day Free Trial													-0.44	0.35	-0.15	-0.12	-0.12

Hinova Pharmaceuticals Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.03 Mil.

Hinova Pharmaceuticals Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Hinova Pharmaceuticals's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Hinova Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hinova Pharmaceuticals Inc (SHSE:688302) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041

Website

http://www.hinovapharma.com

Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

Hinova Pharmaceuticals Headlines

No Headlines